These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38549927)

  • 21. [PET-CT documented complete remission of Erdheim-Chester disease, lasting more than 4 years from treatment initiation with cladribine].
    Adam Z; Řehák Z; Koukalová R; Bortlíček Z; Krejčí M; Pour L; Szturz P; Prášek J; Nebeský T; Adamová Z; Král Z; Mayer J
    Vnitr Lek; 2014; 60(5-6):499, 501-11. PubMed ID: 24974755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Usefulness of combined positron emission tomography and computed tomography imaging in Erdheim-Chester disease].
    Girszyn N; Arnaud L; Villain D; Kahn JE; Piette AM; Bletry O
    Rev Med Interne; 2007 Nov; 28(11):770-4. PubMed ID: 17629593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erdheim-Chester Disease: Two cases from an ophthalmic perspective.
    Brodie J; Zhou S; Makkuni D; Beadsmoore C; Mukhtyar C; Saada J; Bowles KM; Beigi B; Burton BJL
    Am J Ophthalmol Case Rep; 2020 Dec; 20():100984. PubMed ID: 33204897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dabrafenib and Trametinib Treatment for Erdheim-Chester Disease With Brain Stem Involvement.
    Al Bayati A; Plate T; Al Bayati M; Yan Y; Lavi ES; Rosenblatt JD
    Mayo Clin Proc Innov Qual Outcomes; 2018 Sep; 2(3):303-308. PubMed ID: 30225465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erdheim-Chester Disease With BRAF V600E Mutation and Central Diabetes Insipidus Successfully Treated With Glucocorticoid.
    Imaizumi T; Daido H; Kato T; Yabe D
    JCEM Case Rep; 2023 Mar; 1(2):luad014. PubMed ID: 37908458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter study.
    van der Hiel B; Haanen JBAG; Stokkel MPM; Peeper DS; Jimenez CR; Beijnen JH; van de Wiel BA; Boellaard R; van den Eertwegh AJM;
    BMC Cancer; 2017 Sep; 17(1):649. PubMed ID: 28915798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Erdheim-Chester disease : An important differential diagnosis and its main symptoms].
    Knitza J; Kampylafka E; Wacker J; Schett G; Manger B
    Z Rheumatol; 2019 Feb; 78(1):66-71. PubMed ID: 30430236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Erdheim-Chester disease: a rare histiocytosis with outstanding response to cobimetinib.].
    Sosa GA; Dogliani P; Guidi AE; Marangoni MA; Lavarda M; Fainstein-Day P
    Rev Fac Cien Med Univ Nac Cordoba; 2021 Dec; 78(4):398-401. PubMed ID: 34962740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erdheim-Chester disease: a comprehensive review from the ophthalmologic perspective.
    Kanakis M; Petrou P; Lourida G; Georgalas I
    Surv Ophthalmol; 2022; 67(2):388-410. PubMed ID: 34081930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erdheim-Chester disease.
    Campochiaro C; Tomelleri A; Cavalli G; Berti A; Dagna L
    Eur J Intern Med; 2015 May; 26(4):223-9. PubMed ID: 25865950
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Kirchner J; Hatzoglou V; Buthorn JB; Bossert D; Sigler AM; Reiner AS; Ulaner GA; Diamond EL
    Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1154-1165. PubMed ID: 33057928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Erdheim-Chester disease-A histiocytic multisystem disease with unusual renal involvement].
    Dasdelen S; Büschek F
    Internist (Berl); 2020 Sep; 61(9):969-979. PubMed ID: 32785740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chinese Erdheim-Chester disease: clinical-pathology-PET/CT updates.
    Ding H; Li Y; Ruan C; Gao Y; Wang H; Zhang X; Liao Z
    Endocrinol Diabetes Metab Case Rep; 2015; 2015():150055. PubMed ID: 26527559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
    Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
    Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation.
    Haroche J; Cohen-Aubart F; Emile JF; Arnaud L; Maksud P; Charlotte F; Cluzel P; Drier A; Hervier B; Benameur N; Besnard S; Donadieu J; Amoura Z
    Blood; 2013 Feb; 121(9):1495-500. PubMed ID: 23258922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erdheim-Chester Disease Successfully Treated with Front-Line Single-Agent Dabrafenib.
    Salama H; Fahed Alzayed M; Alharbi KG; Khattak Z; Omer MH; Tahir L; ALhejazi A
    Am J Case Rep; 2022 Feb; 23():e935090. PubMed ID: 35171900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FDG PET/CT Findings of Erdheim-Chester Disease: Radiologic Response to a Novel Treatment Regimen.
    Akin EA; Osman M; Ellenbogen AL
    Clin Nucl Med; 2018 May; 43(5):337-340. PubMed ID: 29485431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erdheim-Chester disease (ECD): Case report, clinical and basic investigations, and review of literature.
    Adawi M; Bisharat B; Bowirrat A
    Medicine (Baltimore); 2016 Oct; 95(42):e5167. PubMed ID: 27759649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erdheim-Chester Disease: The Importance of Information Integration.
    Nikonova A; Esfahani K; Chausse G; Probst S; Petrogiannis-Haliotis T; Knecht H; Gyger G
    Case Rep Oncol; 2017; 10(2):613-619. PubMed ID: 28868020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease.
    Haroche J; Abla O
    Hematology Am Soc Hematol Educ Program; 2015; 2015():571-8. PubMed ID: 26637774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.